InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: Titan V post# 42842

Friday, 01/19/2018 1:45:11 PM

Friday, January 19, 2018 1:45:11 PM

Post# of 48316
Gargosky said the response in the two patients treated with Opdivo after ep-il12 was robust....so I would bet that Oncosec gets this into a fast track phase II trial same as PISCES....especially because the response rates in TNBC monotherapy are extremely low. This would probably get breakthrough status designation too.